No controlled trial has tested HBOT on cosmetic skin endpoints, so the anti-aging case rests on mechanism and indirect markers, not proof of visible rejuvenation. The most cited evidence is the Hachmo 2020 trial, where 60 sessions in adults over 64 lengthened telomeres and reduced senescent cells, but that was measured in blood cells, not skin. Retinoids and daily sunscreen still have far stronger evidence for reducing wrinkles. HBOT may support skin quality at the cellular level, with effects that are gradual and subtle rather than dramatic.
- Fibroblast: the dermal cell that produces collagen and elastin, the structural proteins that keep skin firm.
- Telomere: the protective cap at the end of a chromosome that shortens with cellular aging; longer telomeres are a marker of slower aging.
- TEWL (transepidermal water loss): the rate at which water evaporates through the skin, a standard measure of barrier function.
How Does HBOT Affect Skin Aging?
Skin aging involves several processes at once: reduced collagen production by dermal fibroblasts, breakdown of existing collagen and elastin by matrix metalloproteinases, declining microvascular density in the dermis, and accumulation of senescent cells. UV radiation accelerates all of them through oxidative damage and inflammation.
HBOT touches several of these pathways. Collagen synthesis by fibroblasts is oxygen-dependent: it falls in low-oxygen conditions and rises in the high-oxygen state HBOT produces. HBOT also stimulates angiogenesis, improving dermal blood supply, and upregulates antioxidant defenses while dampening inflammatory signaling (Thom, 2011). These are the mechanisms behind its established role in wound healing, and they are the reason a skin-rejuvenation effect is biologically plausible. Plausible is not the same as proven, which is the distinction the rest of this page keeps in view.
What Does the Telomere and Collagen Research Actually Show?
The strongest human data comes from the Hachmo 2020 aging trial (published in Aging), which found significant telomere lengthening and a drop in senescent immune cells after 60 HBOT sessions in adults over 64. Telomere length is a marker of cellular aging, so the finding is genuinely interesting. The important caveat is that it was measured in blood cells, not skin cells. Whether the same systemic effect meaningfully changes aging dermis is an assumption, not a demonstrated result. The telomere data is covered in depth in our HBOT anti-aging telomere data article.
The collagen story is on similarly mechanistic footing. Fibroblast collagen production is oxygen-dependent, and hyperoxia increases collagen output in cell culture and in healing wounds. Wound-healing research shows HBOT increases new collagen deposition, improves fiber organization, and strengthens repaired tissue. Translating that to non-wounded, aging skin requires assuming the same mechanism produces visible improvement in intact dermis, which has not been shown in a controlled cosmetic trial. A 2014 review in Med Gas Research and a 2024 review in Frontiers in Aging both frame HBOT skin rejuvenation as mechanistically reasonable but clinically unproven for cosmetic endpoints. Our wound healing guide covers the underlying evidence base.
Does HBOT Actually Reduce Wrinkles?
There is no randomized controlled trial showing that HBOT reduces wrinkles. That is the honest answer, and it is the single most important point on this page. What exists is mechanistic rationale (collagen synthesis, angiogenesis) plus extrapolation from wound-healing and the systemic aging-marker data above. Compared with the established anti-aging modalities, HBOT’s cosmetic evidence is thin.
The table below places HBOT honestly against the approaches that do have controlled trial evidence.
HBOT vs Established Skin-Rejuvenation Approaches
| Approach | Evidence strength | Primary effect | Typical cost |
|---|---|---|---|
| Retinoids | Strong (RCTs) | Collagen stimulation, wrinkle reduction | $15-80 per product |
| Daily sunscreen | Strong (RCT) | Prevents photoaging (the biggest driver) | $10-40 per product |
| Laser / energy devices | Strong | Collagen remodeling, texture and tone | $500-3,000 per course |
| Chemical peels | Moderate to strong | Surface renewal, pigmentation | $150-1,000 per course |
| HBOT | Emerging (no cosmetic RCT) | Systemic aging markers, collagen support (mechanistic) | $4,500-18,000 per course |
HBOT is by far the most expensive option in the table and the only one without controlled cosmetic evidence. It may complement retinoids and sun protection, but it is not a substitute for them. For a broader view of options, see our HBOT alternatives guide.
How Many Sessions and What Does It Cost?
Cosmetic HBOT is never covered by insurance. Out-of-pocket cost for 30 to 60 sessions runs from roughly $4,500 to $18,000 depending on the facility. The few skin-oriented protocols in use borrow their session counts (30 to 60) from the aging-marker research rather than from any skin-specific trial. Our HBOT cost guide gives current pricing and the session guide explains what each session involves.
If you pursue HBOT for skin, calibrate expectations to the evidence: the risk profile is favorable for healthy adults, but the expected cosmetic effect is subtle and gradual, working from the inside out rather than resurfacing the skin the way a laser or deep peel does. Photographic documentation at baseline and at 60 to 90 days is the only objective way to detect changes that are slow enough to miss day to day. Integrating HBOT with a dermatologist-guided plan (prescription retinoids, daily sunscreen, and, where appropriate, professional resurfacing) is more defensible than using it as a standalone skin treatment. The broader aesthetic and longevity context, including the anti-aging evidence, is worth reviewing before committing.
How many sessions does skin-rejuvenation HBOT require?
There is no established minimum or optimal count for cosmetic skin applications, because no skin-specific trial has defined one. Protocols in use borrow 30 to 60 sessions from the aging-marker research (Hachmo, 2020). Anyone quoting a precise number for cosmetic results is extrapolating beyond the evidence. Session count, pressure, and frequency should be discussed with a hyperbaric physician against realistic, modest expectations.
Can HBOT help with acne scarring?
There is no specific clinical evidence for HBOT in acne scarring. The collagen-stimulating and wound-healing properties are theoretically relevant, since scar remodeling involves fibroblast activity that HBOT supports (Thom, 2011). But established treatments (microneedling, fractional laser, subcision) have far stronger evidence. HBOT is not a first-line option for acne scars and should not be marketed as one.
How long would any skin improvement from HBOT last?
This is unanswered in the literature. Structural changes such as increased collagen density or improved vascularization would be expected to persist for some period after treatment, since they are not states that require ongoing HBOT to maintain. Whether periodic maintenance sessions extend results is speculative, and without controlled cosmetic data any durability claim is an estimate, not a finding.
Sources
- Hachmo Y, Hadanny A, Abu Hamed R, et al. Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial. Aging (Albany NY). 2020;12(22):22445-22456. doi:10.18632/aging.202188
- Asadamongkol B, Zhang JH. The development of hyperbaric oxygen therapy for skin rejuvenation and treatment of photoaging. Med Gas Res. 2014;4:7. PMC3977684
- Hyperbaric oxygen therapy: future prospects in regenerative therapy and anti-aging. Front Aging. 2024. PMC11097100
- Thom SR. Hyperbaric oxygen: its mechanisms and efficacy. Plast Reconstr Surg. 2011;127(Suppl 1):131S-141S. doi:10.1097/PRS.0b013e3181fbe2bf
- Mukherjee S, Date A, Patravale V, et al. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2006;1(4):327-348. doi:10.2147/ciia.2006.1.4.327
- Hughes MCB, Williams GM, Baker P, Green AC. Sunscreen and prevention of skin aging: a randomized trial. Ann Intern Med. 2013;158(11):781-790. doi:10.7326/0003-4819-158-11-201306040-00002
Medical Disclaimer
The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Author
Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.
